Shaanxi Micot Pharmaceutical Technology Co., Ltd.
Clinical trials sponsored by Shaanxi Micot Pharmaceutical Technology Co., Ltd., explained in plain language.
-
New stroke drug shows promise in early trial
Disease control Recruiting nowThis study tests a new drug called MT200605 in 360 people who have had an acute ischemic stroke within the past 24 hours. The drug aims to protect brain cells and reduce damage from the stroke. Participants will receive either a high, medium, or low dose of the drug or a placebo,…
Phase: PHASE2 • Sponsor: Shaanxi Micot Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New Dual-Target drug aims to beat current therapy for kidney Patients' hormone problem
Disease control Recruiting nowThis Phase 3 trial tests a new drug called MT1013 against an existing drug, cinacalcet, in 424 adults on dialysis who have secondary hyperparathyroidism (overactive parathyroid glands). The study aims to see if MT1013 better controls parathyroid hormone levels and improves bone h…
Phase: PHASE3 • Sponsor: Shaanxi Micot Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC